Skip links

Revolutionizing Artificial Intelligence and Diagnostics in The Middle East

The only precision cancer screening,
tailored for the people of the Middle East

is a matter of life and death

Multi-Cancer Early Detection blood test
Powered by AI and Multiomics

Coming soon

Introducing Revonco

Detectiome today announced the first version of its flagship Multi-Cancer Early Detection (MCED): Revonco. Revonco is a blood test capable of detecting multiple types of cancer at the earliest stage before the onset of symptoms when the disease can be effectively treated. It offers the first multiomics precision diagnostic test that is specifically designed and optimized for the unique genetic population of the Middle East, providing unparalleled performance.

Early detection saves lives

However, most cancers have no screening method to be detected early.  Population scale early detection using Detectiome could save up to 2500 lives annually just in the UAE.

One blood test to detect multiple cancers

Why settle for a cancer screening method that only detects one cancer type when you want protection against all?

We understand the impracticality of subjecting individuals to numerous tests for each cancer type. Doctors won't recommend it, patients won't do it, and insurance companies won't cover it.

Life-saving effects of Detectiome vs conventional methods

%

Of Cancer-related deaths are covered in Detectiome and have a chance of early detection.

VS

%

Of cancer-related deaths had a chance to use a related screening method only. The rest didn’t have any chance of early detection.

%

Of Cancer-related deaths are covered in Detectiome and have a chance of early detection.

%

Survival rate when the cancer is detected at an early asymptomatic stage

VS

%

Of cancer-related deaths had a chance to use a related screening method only. The rest didn’t have any chance of early detection.

%

Survival rate when the cancer is detected after symptoms onset

%

Survival rate when the cancer is detected at an early asymptomatic stage

VS

%

Survival rate when the cancer is detected after symptoms onset

On the edge of Artificial Intelligence

Our unique and powerful AI model enables product development tailored to local genetic backgrounds. 

AI-Multiomics

Be on
the bleeding-edge

By using state of the art AI-Multiomics technology, Detectiome can be one of the greatest places to be on the edge of technology and science, learn from your colleagues and share your wisdom and experience to save lives.

Media Spotlight & Awards

AWARDS

Healthtech
Startup of the year

We're thrilled to announce that Detectiome has been awarded the Healthtech Startup of the Year by Entrepreneur Magazine at the Enterprise Agility Awards 2022. This recognition is a testament to our team's dedication to improving cancer detection through innovative technologies.

In the MEDIA

The Middle East’s biotech plans are taking shape – & how

Our startup, Detectiome, is now being recognized and featured on FastCompany Middle East's website.

Wanna be a part of the future?
Let’s talk.

    Digital Solutions for

    Adjust your design through a wide range of theme options in the WordPress Customizer and see the changes instantly.

    Developers 🔋Agencies 💡Businesses ✏️DesignerseCommerce 📝Freelancers ⚡PeopleManagers 👨‍💼

    This website uses cookies to improve your web experience.